A Nigerian Perspective on Lassa Vaccine Development: CEPI Roundtable

This week, our CEO, Professor Chimezie Anyakora, participated in the CEPI (Coalition for Epidemic Preparedness Innovations) CSOs roundtable event, organized by Nigeria Health Watch, where the discussion focused on “Civil Society Engagement in Lassa Vaccine Development: A Nigerian Perspective.”

The event brought together high-level stakeholders who shared valuable insights. A key highlight was the address by CEPI (Coalition for Epidemic Preparedness Innovations)’s CEO, Richard Hatchett, who emphasized the importance of equity and access in vaccine development.

At Bloom Public Health, we remain steadfast in our commitment to advancing conversations around strengthening the vaccine ecosystem. Through the African Vaccine Academy (AVA), we are bolstering Africa’s capacity for vaccine development and manufacturing, enhancing self-reliance and ensuring long-term sustainability in the supply of safe and quality-assured vaccines across the continent.